ONCOLOGY Vol 13 No 7_Suppl_3 | Oncology

Adjuvant Treatment of Early Stage Non–Small-Cell Lung Cancer

July 01, 1999

Cure rates for non–small-cell lung cancer (NSCLC) remain low and the prognosis for patients with even stage IA disease is poor. Complete surgical resection is still the first-line treatment for NSCLC, but many investigators